BDNF sensitizes bone and joint afferent neurons at different stages of MIA-induced osteoarthritis
Bone · 2024
DOI: 10.1016/j.bone.2024.117260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2024. Verfasst von Michael Morgan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Physiology, University of Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Receptor, trkB, Osteoarthritis, Bone and Bones. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
There is emerging evidence that Brain Derived Neurotrophic Factor (BDNF), and one of its receptors TrkB, play important roles in the pathogenesis of osteoarthritis (OA) pain. Whilst these studies clearly highlight the potential for targeting BDNF/TrkB signaling to treat OA pain, the mechanism for how BDNF/TrkB signaling contributes to OA pain remains unclear. In this study, we used an animal model of mono-iodoacetate (MIA)-induced OA, in combination with electrophysiology, behavioral testing, Western blot analysis, and retrograde tracing and immunohistochemistry, to identify roles for BDNF/TrkB signaling in the pathogenesis of OA pain. We found that: 1) TrkB is expressed in myelinated medium diameter neurons that innervate the knee joint and bone in naïve animals; 2) peripheral application of BDNF increases the sensitivity of Aδ, but not C knee joint and bone afferent neurons, in response to mechanical stimulation, in naïve animals; 3) BDNF expression increases in synovial tissue in early MIA-induced OA, when pathology is confined to the joint, and in the subchondral bone in late MIA-induced OA, when there is additional damage to the surrounding bone; and 4) TrkB inhibition reverses MIA-induced changes in the sensitivity of Aδ but not C knee joint afferent neurons early in MIA-induced OA, and Aδ but not C bone afferent neurons late in MIA-induced OA. Our findings suggest that BDNF/TrkB signaling may have a role to play in the pathogenesis of OA pain, through effects on knee joint afferent neurons early in disease when there is inflammation confined to the joint, and bone afferent neurons late in disease when there is involvement of damage to subchondral bone. Targeted manipulation of BDNF/TrkB signaling may provide therapeutic benefit for the management of OA pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Physiology, University of Melbourne, Victoria, Australia.
- Department of Biochemistry and Pharmacology, University of Melbourne, Victoria, Australia.
- Department of Anatomy and Physiology, University of Melbourne, Victoria, Australia. Electronic address: j.ivanusic@unimelb.edu.au.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Morgan, M., Nazemian, V., Thai, J., Lin, I., Northfield, S., & Ivanusic, J. J. (2024). BDNF sensitizes bone and joint afferent neurons at different stages of MIA-induced osteoarthritis. Bone. https://doi.org/10.1016/j.bone.2024.117260
Vancouver
Morgan M, Nazemian V, Thai J, Lin I, Northfield S, Ivanusic JJ. BDNF sensitizes bone and joint afferent neurons at different stages of MIA-induced osteoarthritis. Bone. 2024. doi:10.1016/j.bone.2024.117260
BibTeX
@article{Morgan2024,
author = {Morgan, Michael and Nazemian, Vida and Thai, Jenny and Lin, Irene and Northfield, Susan and Ivanusic, Jason J},
title = {BDNF sensitizes bone and joint afferent neurons at different stages of MIA-induced osteoarthritis},
journal = {Bone},
year = {2024},
doi = {10.1016/j.bone.2024.117260}
}
EUVIMED